Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ocugen Inc (OCGN)

0.623   0.025 (4.2%) 08-13 16:00
Open: 0.6465 Pre. Close: 0.5979
High: 0.648 Low: 0.58
Volume: 18,520,768 Market Cap: 84M
Ocugen, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. The company offers an ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules, as well as targets a range of retinal and ocular surface diseases. Its pipeline includes OCU400 and OCU410 for the treatment of inherited retinal disorders; OCU200 for the treatment of wet-AMD, DME, and diabetic retinopathy; OCU100 for retinitis pigmentosa; and OCU300, which is in Phase III clinical trial for the treatment of ocular graft versus host diseases. The company has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing. Ocugen, Inc. is based in Malvern, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.65 - 0.654 0.654 - 0.657
Low: 0.573 - 0.576 0.576 - 0.579
Close: 0.615 - 0.62 0.62 - 0.625

Technical analysis

as of: 2020-08-13 4:36:57 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.12     One year: 1.31
Support: Support1: 0.48    Support2: 0.19
Resistance: Resistance1: 0.96    Resistance2: 1.12
Pivot: 0.56
Moving Average: MA(5): 0.62     MA(20): 0.50
MA(100): 0.33     MA(250): 2.09
MACD: MACD(12,26): 0.08     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 48.23     %D(3): 51.15
RSI: RSI(14): 61.42
52-week: High: 17.40  Low: 0.17  Change(%): -94.4
Average Vol(K): 3-Month: 3631179  10-Days: 3253548

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
OCGN has closed below upper band by 32.8%. Bollinger Bands are 87.5% wider than normal. The large width of the bands suggest high volatility as compared to OCGN's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue.

Headline News

Fri, 14 Aug 2020
Ocugen Provides Business Update and Second Quarter 2020 Financial Results - GlobeNewswire

Thu, 13 Aug 2020
Fresh Data-Based Insight On Ocugen, Inc. (OCGN) - Stocks Register

Thu, 13 Aug 2020
Renewed Optimism is Surrounding Ocugen Inc. (NASDAQ:OCGN) - The Oracle Dispatch

Wed, 12 Aug 2020
A New Orphan Drug Designation Gives Hope to Ocugen Stock - InvestorPlace

Wed, 12 Aug 2020
Ocugen Investors Are Missing the Obvious Signs of Failure -

Wed, 12 Aug 2020
Why Ocugen, Inc. (OCGN) Is 'Ahead Of Itself ' - The News Heater

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 135
Shares Float (M) 61
% Held by Insiders 8.15
% Held by Institutions 11.98
Shares Short (K) 325
Shares Short P. Month (K) 311

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm) -119.2
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.098
Qtrly Earnings Growth
Operating Cash Flow (M) -19
Levered Free Cash Flow (M) -23

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -4.45

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.